Sign in or create an account to add this stock to your watchlist.
Aphria Inc. produces, supplies, and sells medical cannabis in Canada. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders. The company sells its products through its online store or phones, as well as engages in the wholesale shipping of medical marijuana plant cuttings and dried buds to other licensed producers. Aphria Inc. is headquartered in Leamington, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
SymbolTSE:APH
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins75.91%
Return on Equity7.63%
Return on Assets6.72%
Miscellaneous
EmployeesN/A
Outstanding Shares177,698,000
Aphria (TSE:APH) Frequently Asked Questions
What is Aphria's stock symbol?
Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APH."
When is Aphria's next earnings date?
What price target have analysts set for APH?
1 brokers have issued 12 month price objectives for Aphria's shares. Their predictions range from C$25.00 to C$26.50. On average, they anticipate Aphria's stock price to reach C$25.75 in the next year. View Analyst Ratings for Aphria.
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include Valeant Pharmaceuticals International (VRX), Canopy Growth (WEED), Aurora Cannabis (ACB), Stada Arzneimittel (SAZ), Hikma Pharmaceuticals (HKMPY), Hikma Pharmaceuticals (HIK), MedReleaf (LEAF), Hydropothecary (THCX), OrganiGram (OGI), Supreme Cannabis (FIRE), OrganiGram (OGRMF), Medical Marijuana (MJNA), Benchmark (BMK), MPX Bioceutical (MPX) and ICC Labs (ICC).
Who are Aphria's key executives?
Aphria's management team includes the folowing people:
- Mr. Victor Neufeld, Chair of the Board of Directors, CEO & Pres (Age 64)
- Mr. Cole Cacciavillani, Co-Founder, COO, VP of Growing Operations & Director (Age 63)
- Mr. John Cervini, Co-Founder, Chief Agronomist Officer, VP of Infrastructure & Technology and Director
- Mr. Carl A. Merton, Chief Financial Officer
- Ms. Megan McCrae, Director of Marketing
Has Aphria been receiving favorable news coverage?
News headlines about APH stock have trended somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Aphria earned a coverage optimism score of 0.19 on Accern's scale. They also gave news headlines about the company an impact score of 46.61 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
How do I buy shares of Aphria?
Shares of APH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Aphria's stock price today?
One share of APH stock can currently be purchased for approximately C$12.56.
How big of a company is Aphria?
Aphria has a market capitalization of C$2.31 billion.
MarketBeat Community Rating for Aphria (APH)
MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APH will underperform the S&P 500 over the long term. You may vote once every thirty days.
Aphria (TSE:APH) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Aphria in the last 12 months. Their average twelve-month price target is C$25.75, suggesting that the stock has a possible upside of 105.02%. The high price target for APH is C$26.50 and the low price target for APH is C$25.00. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | N/A |
| Consensus Rating Score: | 2.00 | 2.00 | 2.00 | N/A |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | C$25.75 | C$25.75 | C$25.75 | N/A |
| Price Target Upside: | 105.02% upside | 44.58% upside | 44.58% upside | N/A |
Aphria (TSE:APH) Consensus Price Target History
Aphria (TSE:APH) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 1/30/2018 | Canaccord Genuity | Boost Price Target | | C$23.50 ➝ C$26.50 |  |
| 1/11/2018 | Pi Financial | Boost Price Target | | C$14.00 ➝ C$25.00 | |
(Data available from 5/23/2016 forward)
Aphria (TSE:APH) Dividend Information
Aphria pays an annual dividend of C$0.76 per share, with a dividend yield of 6.05%.
| Annual Dividend: | $0.76 |
| Dividend Yield: | 6.05% |
| Payout Ratio(s): | N/A |
Aphria (TSE:APH) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Aphria (TSE APH) Insider Trading and Institutional Ownership History
Aphria (TSE APH) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Aphria (TSE APH) News Headlines
| Source: |
|
Aphria (TSE:APH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Aphria (TSE APH) Stock Chart for Wednesday, May, 23, 2018
Loading chart…
